Clearance Summary
STIMPOD NMS460 Nerve Stimulator received FDA 510(k) clearance under submission number K252712, sponsored by Algiamed Technologies USA, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2026-05-28.
- Submission: K252712
- Applicant / Sponsor: Algiamed Technologies USA, Inc.
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5890
- Decision date: 2026-05-28
Classification & Regulation
This clearance is catalogued under FDA product code GZJ and 21 CFR 882.5890, within the Neurology review panel as a Class II device.